Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells.

Komiya E, Ohnuma K, Yamazaki H, Hatano R, Iwata S, Okamoto T, Dang NH, Yamada T, Morimoto C.

Biochem Biophys Res Commun. 2014 May 16;447(4):609-15. doi: 10.1016/j.bbrc.2014.04.037. Epub 2014 Apr 18.

PMID:
24747072
2.

Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.

Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M, Samarzija M, Brcic L, Kern I, Rozman A, Popper H, Zöchbauer-Müller S, Heller G, Altenberger C, Ziegler B, Klepetko W, Berger W, Dome B, Hegedus B.

J Pathol. 2015 Oct;237(2):203-14. doi: 10.1002/path.4567. Epub 2015 Jul 14.

PMID:
26011651
3.

Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.

Alì G, Borrelli N, Riccardo G, Proietti A, Pelliccioni S, Niccoli C, Boldrini L, Lucchi M, Mussi A, Fontanini G.

J Thorac Oncol. 2013 Nov;8(11):1389-95. doi: 10.1097/JTO.0b013e3182a59f45.

4.

CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells.

Okamoto T, Iwata S, Yamazaki H, Hatano R, Komiya E, Dang NH, Ohnuma K, Morimoto C.

PLoS One. 2014 Jan 23;9(1):e86671. doi: 10.1371/journal.pone.0086671. eCollection 2014.

5.

ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.

Cheng YY, Kirschner MB, Cheng NC, Gattani S, Klebe S, Edelman JJ, Vallely MP, McCaughan BC, Jin HC, van Zandwijk N, Reid G.

J Thorac Oncol. 2013 Oct;8(10):1317-28. doi: 10.1097/JTO.0b013e3182a0840a.

6.

Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.

You M, Varona-Santos J, Singh S, Robbins DJ, Savaraj N, Nguyen DM.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):508-16. doi: 10.1016/j.jtcvs.2013.08.035. Epub 2013 Oct 4.

7.

Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.

Greillier L, Tounsi A, Berenguer-Daizé C, Dussault N, Delfino C, Benyahia Z, Cayol M, Mabrouk K, Garcia S, Martin PM, Barlesi F, Ouafik L.

J Thorac Oncol. 2016 Jan;11(1):94-107. doi: 10.1016/j.jtho.2015.09.004.

8.

CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma.

Aoe K, Amatya VJ, Fujimoto N, Ohnuma K, Hosono O, Hiraki A, Fujii M, Yamada T, Dang NH, Takeshima Y, Inai K, Kishimoto T, Morimoto C.

Clin Cancer Res. 2012 Mar 1;18(5):1447-56. doi: 10.1158/1078-0432.CCR-11-1990. Epub 2012 Jan 18.

9.

Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1α-MUC1 pathway.

Goudarzi H, Iizasa H, Furuhashi M, Nakazawa S, Nakane R, Liang S, Hida Y, Yanagihara K, Kubo T, Nakagawa K, Kobayashi M, Irimura T, Hamada J.

Cancer Lett. 2013 Oct 1;339(1):82-92. doi: 10.1016/j.canlet.2013.07.020. Epub 2013 Jul 20.

PMID:
23879962
10.

Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma.

Yamamoto J, Ohnuma K, Hatano R, Okamoto T, Komiya E, Yamazaki H, Iwata S, Dang NH, Aoe K, Kishimoto T, Yamada T, Morimoto C.

Br J Cancer. 2014 Apr 29;110(9):2232-45. doi: 10.1038/bjc.2014.151. Epub 2014 Apr 17.

11.

Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma.

Mogi A, Koga K, Aoki M, Hamasaki M, Uesugi N, Iwasaki A, Shirakusa T, Tamura K, Nabeshima K.

Virchows Arch. 2013 Jan;462(1):83-93. doi: 10.1007/s00428-012-1344-6. Epub 2012 Nov 28.

PMID:
23187830
12.

Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells.

Horio M, Sato M, Takeyama Y, Elshazley M, Yamashita R, Hase T, Yoshida K, Usami N, Yokoi K, Sekido Y, Kondo M, Toyokuni S, Gazdar AF, Minna JD, Hasegawa Y.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S634-45. doi: 10.1245/s10434-011-2142-0. Epub 2011 Nov 16.

13.

The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.

Tucker TA, Dean C, Komissarov AA, Koenig K, Mazar AP, Pendurthi U, Allen T, Idell S.

Am J Respir Cell Mol Biol. 2010 Jun;42(6):685-96. doi: 10.1165/rcmb.2008-0433OC. Epub 2009 Jul 27.

14.

Clinical significance of soluble CD26 in malignant pleural mesothelioma.

Fujimoto N, Ohnuma K, Aoe K, Hosono O, Yamada T, Kishimoto T, Morimoto C.

PLoS One. 2014 Dec 19;9(12):e115647. doi: 10.1371/journal.pone.0115647. eCollection 2014.

15.

Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.

Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce CM, Pass HI, Blandino G.

Oncogene. 2014 Nov 13;33(46):5319-31. doi: 10.1038/onc.2013.476. Epub 2013 Nov 18.

16.

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.

Tsao AS, He D, Saigal B, Liu S, Lee JJ, Bakkannagari S, Ordonez NG, Hong WK, Wistuba I, Johnson FM.

Mol Cancer Ther. 2007 Jul;6(7):1962-72.

17.

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.

Ortolan E, Giacomino A, Martinetto F, Morone S, Lo Buono N, Ferrero E, Scagliotti G, Novello S, Orecchia S, Ruffini E, Rapa I, Righi L, Volante M, Funaro A.

Oncotarget. 2014 Aug 15;5(15):6191-205.

18.

AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.

Sudo H, Tsuji AB, Sugyo A, Abe M, Hino O, Saga T.

Int J Oncol. 2014 Feb;44(2):530-8. doi: 10.3892/ijo.2013.2183. Epub 2013 Nov 20.

PMID:
24253341
19.

Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.

Schramm A, Opitz I, Thies S, Seifert B, Moch H, Weder W, Soltermann A.

Eur J Cardiothorac Surg. 2010 Mar;37(3):566-72. doi: 10.1016/j.ejcts.2009.08.027. Epub 2009 Sep 24.

PMID:
19781955
20.

GAS5 long non-coding RNA in malignant pleural mesothelioma.

Renganathan A, Kresoja-Rakic J, Echeverry N, Ziltener G, Vrugt B, Opitz I, Stahel RA, Felley-Bosco E.

Mol Cancer. 2014 May 23;13:119. doi: 10.1186/1476-4598-13-119.

Supplemental Content

Support Center